Low MAP (70 ± 13 mmHg vs. 81 ± 14 mmHg, P < 0.001), oliguria (14.4% vs. 2.6%, P < 0.001), anemia (102 ± 23 g/L vs. 116 ± 21 g/L, P < 0.001), a lower prealbumin level (139 g/L vs. 200 g/L, P < 0.001), and hypoalbuminemia (30.8 ± 5.1 g/L vs. 36.0 ± 5.1 g/L, P < 0.001), higher uric acid (424.4 μmol/L vs. 355.0 μmo/L, P < 0.001) level, magnesium (1.0 mmol/L vs. 0.9 mmo/L, P = 0.009) level and phosphate (1.3 mmol/L vs. 1.2 mmo/L, P < 0.001) level were more frequent among non-survivors. The gene discussed is TTR; the disease is anemia.